These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 14066988)

  • 1. [EFFECT OF VARIOUS PSYCHOSOCIAL FACTORS ON THE EFFECTIVENESS OFDRUG THERAPY OF SCHIZOPHRENIC PATIENTS].
    JUS A; WARDASZKO H
    Neurol Neurochir Psychiatr Pol; 1963; 13():385-90. PubMed ID: 14066988
    [No Abstract]   [Full Text] [Related]  

  • 2. FIRST ADMITTED SCHIZOPHRENICS IN DRUG ERA; FOLLOW-UP ANOKA SCHIZOPHRENIC COHORT, 1956-1958.
    PETERSON DB; OLSON GW
    Arch Gen Psychiatry; 1964 Aug; 11():137-44. PubMed ID: 14237609
    [No Abstract]   [Full Text] [Related]  

  • 3. PHARMACOLOGIC TREATMENT.
    MALITZ S
    Int Psychiatry Clin; 1964 Oct; 1():945-69. PubMed ID: 14276084
    [No Abstract]   [Full Text] [Related]  

  • 4. Brief-contact therapy and drugs in outpatient treatment.
    Koegler RR
    Int Psychiatry Clin; 1966; 3(4):139-54. PubMed ID: 5339272
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuropsychopharmacology and the genetics of schizophrenia: a history of the diagnosis of schizophrenia.
    Ban TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):753-62. PubMed ID: 15363601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacology of schizophrenia in children and adolescents.
    Carlisle LL; McClellan J
    Pediatr Clin North Am; 2011 Feb; 58(1):205-18, xii. PubMed ID: 21281857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology and the "deteriorated" schizophrenic patient.
    COHEN S; PILLSBURY RM
    Dis Nerv Syst; 1960 Dec; 21():677-9. PubMed ID: 13694428
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE REHABILITATION AND READJUSTMENT OF SCHIZOPHRENIC PATIENTS (REVIEW OF THE LITERATURE)].
    ZHARIKOV NM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1963; 63():1266-70. PubMed ID: 14125827
    [No Abstract]   [Full Text] [Related]  

  • 9. Trial of Ro 1-9569/12 on a group of apathetic chronic schizophrenic patients.
    WECKOWICZ TE; WARD T; HOFFER A
    Am J Psychiatry; 1960 Apr; 116():930-1. PubMed ID: 13843367
    [No Abstract]   [Full Text] [Related]  

  • 10. Pimozide in chronic schizophrenic patients.
    Huber W; Serafetinides EA; Colmore JP; Clark M
    J Clin Pharmacol New Drugs; 1971; 11(4):304-9. PubMed ID: 4932748
    [No Abstract]   [Full Text] [Related]  

  • 11. On the usefulness of the placebo and of the double-blind technique in the evaluation of psychotropic drugs.
    Tétreault L; Bordeleau JM
    Psychopharmacol Bull; 1971 Jul; 7(3):44-64. PubMed ID: 4940648
    [No Abstract]   [Full Text] [Related]  

  • 12. Algorithm for the treatment of schizophrenia in Japan.
    Sato M; Kubota Y; Ito C; Nakane N; Hayashida M; Koshino Y; Uchimura H; Tsutsumi T; Koyama T; Kusumi I; Akiyama K; Hamamura T; Saito H; Saijo T; Nishikawa T; Kuroda Y; Fujiwara Y; Higuchi T; Yamawaki S
    Int J Psychiatry Clin Pract; 1999; 3(4):271-6. PubMed ID: 24921231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [8th symposium of the Workshop for Neurospychopharmacology and Pharmacopsychiatry (AGNP) at Nuremberg, 26-29 October 1977. Pathophysiology and psychopharmacology of schizophrenic psychoses. Proceedings].
    Arzneimittelforschung; 1978; 28(9):1481-538. PubMed ID: 38805
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-therapy related changes in the history of schizophrenia during 2 different stages in the development of psychopharmacology].
    Avrutskiĭ GIa; Gurovich IIa; Zaĭtsev SG; Ezhkov AA; Magalif AIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(9):1376-84. PubMed ID: 4608160
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent developments in psychosocial treatments for schizophrenic patients.
    Shean GD
    Expert Rev Neurother; 2007 Jul; 7(7):817-27. PubMed ID: 17610389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A group approach to psychopharmacology with schizophrenics.
    Skolnick MR
    Yale J Biol Med; 1985; 58(4):317-26. PubMed ID: 2864762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modifications in the style of painting of a schizophrenic treated with Tofranil].
    GAMNA G
    Minerva Med; 1960 Dec; 51():4416-37. PubMed ID: 13703284
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia.
    Alam DA; Janicak PG
    Essent Psychopharmacol; 2005; 6(3):127-40. PubMed ID: 15869020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicine. What are the right targets for psychopharmacology?
    Hyman SE; Fenton WS
    Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.